111 related articles for article (PubMed ID: 7490443)
1. Adjuncts to antibacterial therapy.
Frank MO; Mandell GL
Infect Dis Clin North Am; 1995 Sep; 9(3):769-81. PubMed ID: 7490443
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic use of cytokines to modulate phagocyte function for the treatment of infectious diseases: current status of granulocyte colony-stimulating factor, granulocyte-macrophage colony-stimulating factor, macrophage colony-stimulating factor, and interferon-gamma.
Hübel K; Dale DC; Liles WC
J Infect Dis; 2002 May; 185(10):1490-501. PubMed ID: 11992286
[TBL] [Abstract][Full Text] [Related]
3. Granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor: comparisons and potential for use in the treatment of infections in nonneutropenic patients.
Root RK; Dale DC
J Infect Dis; 1999 Mar; 179 Suppl 2():S342-52. PubMed ID: 10081506
[TBL] [Abstract][Full Text] [Related]
4. Biologicals and hematopoietic cytokines in prevention or treatment of infections in immunocompromised hosts.
Roilides E; Pizzo PA
Hematol Oncol Clin North Am; 1993 Aug; 7(4):841-64. PubMed ID: 7689074
[TBL] [Abstract][Full Text] [Related]
5. Immunomodulation with interferon-gamma and colony-stimulating factors for refractory fungal infections in patients with leukemia.
Dignani MC; Rex JH; Chan KW; Dow G; deMagalhaes-Silverman M; Maddox A; Walsh T; Anaissie E
Cancer; 2005 Jul; 104(1):199-204. PubMed ID: 15929126
[TBL] [Abstract][Full Text] [Related]
6. Granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor: double-edged swords.
Wilson RF; Henry TD
J Am Coll Cardiol; 2005 Nov; 46(9):1649-50. PubMed ID: 16256863
[No Abstract] [Full Text] [Related]
7. Morphologic and quantitative alterations in hematopoietic cells associated with growth factor therapy: review of the literature.
Schmitz LL; Litz CE; Brunning RD
Hematol Pathol; 1994; 8(3):55-73. PubMed ID: 7527020
[No Abstract] [Full Text] [Related]
8. Comparison of interferon-gamma, granulocyte colony-stimulating factor, and granulocyte-macrophage colony-stimulating factor for priming leukocyte-mediated hyphal damage of opportunistic fungal pathogens.
Gaviria JM; van Burik JA; Dale DC; Root RK; Liles WC
J Infect Dis; 1999 Apr; 179(4):1038-41. PubMed ID: 10068606
[TBL] [Abstract][Full Text] [Related]
9. [More efforts should be made to improve the level of diagnosis and treatment of infectious diseases of newborn infants].
Huang DM; Tong XM
Zhonghua Er Ke Za Zhi; 2003 Dec; 41(12):881-3. PubMed ID: 14723803
[No Abstract] [Full Text] [Related]
10. [Cytokines in the treatment of blood diseases].
Robak T
Acta Haematol Pol; 1995; 26(2 Suppl 1):72-8. PubMed ID: 7544526
[TBL] [Abstract][Full Text] [Related]
11. [Cutaneous side effects of clinically relevant cytokine therapies].
Trefzer U; Hofmann M; Sterry W
Dtsch Med Wochenschr; 2003 Aug; 128(34-35):1782-7. PubMed ID: 12934174
[No Abstract] [Full Text] [Related]
12. A tale of two growth factors.
Fruehauf JP; Kong KM; Wong SF; Chan HO
Pharmacotherapy; 2006 Mar; 26(3):443-4; discussion 444. PubMed ID: 16503728
[No Abstract] [Full Text] [Related]
13. Successful treatment of a generalized human papillomavirus infection with granulocyte-macrophage colony-stimulating factor and interferon gamma immunotherapy in a patient with a primary immunodeficiency and cyclic neutropenia.
Gaspari AA; Zalka AD; Payne D; Menegus M; Bunce LA; Abboud CN; Tyring SK
Arch Dermatol; 1997 Apr; 133(4):491-6. PubMed ID: 9126013
[TBL] [Abstract][Full Text] [Related]
14. [Rational therapy with G-CSF and GM-CSF].
Link H; Herrmann F; Welte K; Aulitzky WE; Ganser A; Kern WV; Meyer P; Schrappe M; Schmoll HJ; Werdan K
Med Klin (Munich); 1994 Aug; 89(8):429-41. PubMed ID: 7526144
[No Abstract] [Full Text] [Related]
15. [The dilemma of stimulating factors in the recovery from chemotherapeutic neutropenia].
Borbollo Escoboza JR; González Avante M; Alvarado Ibarra M
Rev Invest Clin; 1996; 48(4):328. PubMed ID: 8966397
[No Abstract] [Full Text] [Related]
16. Differential immunostimulating effect of granulocyte-macrophage colony-stimulating factor (GM-CSF), granulocyte colony-stimulating factor (G-CSF) and interferon gamma (IFNgamma) after severe trauma.
Lendemans S; Kreuzfelder E; Waydhas C; Schade FU; Flohé S
Inflamm Res; 2007 Jan; 56(1):38-44. PubMed ID: 17334669
[TBL] [Abstract][Full Text] [Related]
17. Long-term outcome of patients treated with hematopoietic growth factors for idiosyncratic drug-induced agranulocytosis.
Andrès E; Noel E; Maloisel F
Am J Med; 2004 Mar; 116(5):354. PubMed ID: 14984824
[No Abstract] [Full Text] [Related]
18. Cytokine therapy of mycobacterial infections.
Holland SM
Adv Intern Med; 2000; 45():431-52. PubMed ID: 10635058
[TBL] [Abstract][Full Text] [Related]
19. Advances in the clinical use of granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor to intensify cancer chemotherapy.
Fisher DC; Peters WP
Curr Opin Hematol; 1994 May; 1(3):221-7. PubMed ID: 9371286
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic use of colony stimulating factors for established neutropenic fever.
Walton SM
W V Med J; 1998; 94(1):26-8. PubMed ID: 9505567
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
